Scientists discover biologics with lesser side effects

Scientists discover biologics with lesser side effects

11:19 AM, 22nd December 2014
Scientists discover biologics with lesser side effects
A new group of molecules called SyAM-Ps can prompt the immune system to attack prostate cancer cells.

WASHINGTON DC, US: Promising treatments known as biologics are on the market and under development for many serious illnesses such as cancer, but some of them come with high risks, even lethal ones. Now scientists have produced a novel class of molecules that could be as effective but without the dangerous side effects. They reported their work on these compounds, which they tested on prostate cancer cells, in ACS’ Journal of the American Chemical Society.

Researcher David A Spiegel and colleagues explained that biologics are protein-based therapies that have revolutionized cancer treatment over the past decade. These compounds work by latching onto malignant cells and then triggering the immune system to destroy them - an approach known as immunotherapy. More than 400 kinds are currently undergoing testing in clinical trials. Although they’re very effective at clearing out cancer cells, biologics have serious drawbacks - including potentially fatal allergic reactions - that are mainly due to their relatively large size. Spiegel’s team wanted to develop an alternative that would be just as effective but without the risks.

The researchers produced a set of molecules that they call synthetic antibody mimics, or SyAMs. These molecules act like biologics by sparking an immune response but are far smaller. In lab tests, a subgroup called SyAM-Ps worked well against prostate cancer cells. Because of their small size, the researchers suggest that SyAMs could avoid many of the pitfalls that have plagued biologics. The compounds could represent an entirely new direction in immunotherapy for treating cancer and other diseases, the researchers concluded.

 

© American Chemical Society News

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


Laser light on nanoparticle photocell converts sunlight into electricity

EUGENE, US: Four pulses of laser light on nanoparticle photocells in a University of Oregon spectroscopy experiment has opened a window on how capture ...

Read more
PPG to acquire automotive specialty materials manufacturer, Revocoat

PITTSBURGH, US: PPG Industries has entered into exclusive negotiations with the AXSON Group to acquire Revocoat, a global supplier of sealants, adhesi ...

Read more
New drug for ebola may originate from Bangalore, India

BANGALORE, INDIA: India may well be the place where the drug to fight the killer Ebola virus originates, with two drug candidates discovered in Bangal ...

Read more
Chevron Phillips to build polyethylene pilot plant in Bartlesville, US

THE WOODLANDS, US: Chevron Phillips Chemical Company LP plans to build a state-of-the-art polyethylene pilot plant at its research and technology faci ...

Read more
Eastman to increase ester alcohol capacity in Texas, US

KINGSPORT, US: Eastman Chemical Company announced a planned increase in its Eastman Texanol ester alcohol manufacturing capacity in Longview, Texas, U ...

Read more
Graphene oxide paper can improve rechargeable batteries, finds new study

KANSAS, US: A Kansas State University engineering team has discovered some of graphene oxide’s important properties that can improve sodium- and ...

Read more